Mutational analysis of the necdin gene in patients with congenital isolated hypogonadotropic hypogonadism
Carregando...
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2011
Editora
BIOSCIENTIFICA LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
IYER, Anita K.
YIP, Kathleen
MELLON, Pamela L.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
EUROPEAN JOURNAL OF ENDOCRINOLOGY, v.165, n.1, p.145-150, 2011
Resumo
Context: Necdin activates GNRH gene expression and is fundamental for the development, migration, and axonal extension of murine GNRH neurons. In humans, necdin plays a potential role in the hypogonadotropic hypogonadism phenotype in patients with Prader-Willi syndrome. Aim: To investigate necdin gene (NDN) variants in patients with isolated hypogonadotropic hypogonadism (IHH). Patients and methods: We studied 160 Brazilian patients with IHH, which includes 92 with Kallmann syndrome and 68 with normosmic IHH. Genomic DNA was extracted and the single NDN exon was amplified and sequenced. To measure GNRH transcriptional activity, luciferase reporter plasmids containing GNRH regulatory regions were transiently transfected into GT1-7 cells in the presence and absence of overexpressed wild-type or mutant necdin. Results: A heterozygous variant of necdin, p.V318A, was identified in a 23-year-old male with Kallmann syndrome. The p.V318A was also present in affected aunt and his father and was absent in 100 Brazilian control subjects. Previous FGFR1 gene analysis revealed a missense mutation (p.P366L) in this family. Functional studies revealed a minor difference in the activation of GNRH transcription by mutant protein compared with wild type in that a significant impairment of the necdin protein activity threshold was observed. Conclusion: A rare variant of necdin (p.V318A) was described in a family with Kallmann syndrome associated with a FGFR1 mutation. Familial segregation and in vitro analysis suggested that this non-synonymous variant did not have a direct causative role in the hypogonadism phenotype. NDN mutations are not a frequent cause of congenital IHH.
Palavras-chave
Referências
- Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
- Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910
- Silveira LFG, 2010, MOL CELL ENDOCRINOL, V324, P30, DOI 10.1016/j.mce.2010.02.023
- Givens ML, 2005, J BIOL CHEM, V280, P19156, DOI 10.1074/jbc.M502004200
- Taniura H, 2005, J CELL BIOCHEM, V94, P804, DOI 10.1002/jcb.20345
- MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E
- Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160
- Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521
- Kim HG, 2008, AM J HUM GENET, V83, P511, DOI 10.1016/j.ajhg.2008.09.005
- Chan YM, 2009, P NATL ACAD SCI USA, V106, P11703, DOI 10.1073/pnas.0903449106
- Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884
- Trarbach EB, 2006, J CLIN ENDOCR METAB, V91, P4006, DOI 10.1210/jc.2005-2793
- Miller NLG, 2009, HUM MOL GENET, V18, P248, DOI 10.1093/hmg/ddn344
- Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103
- Carlton VEH, 2003, NAT GENET, V34, P91, DOI 10.1038/ng1147
- Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101
- Goldstone AP, 2004, TRENDS ENDOCRIN MET, V15, P12, DOI 10.1016/j.tem.2003.11.003
- Davidson TM, 1998, ANN NY ACAD SCI, V855, P787, DOI 10.1111/j.1749-6632.1998.tb10659.x
- GEVAELDAR T, 2010, EUROPEAN J ENDOCRINO, V162, P377, DOI 10.1530/EJE-09-0901
- Givens ML, 2004, MOL ENDOCRINOL, V18, P2950, DOI 10.1210/me.2003-0437
- Iyer AK, 2010, MOL ENDOCRINOL, V24, P1949, DOI 10.1210/me.2010-0156
- Kelley CG, 2002, MOL ENDOCRINOL, V16, P2413, DOI 10.1210/ma.2002.0189
- Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009